References
- Wolff K, Side-effects of psoralen photochemotherapy (PUVA). Br J Dermatol (1990) 122 (suppl 36): 117–25.
- Stern RS, Nichols KT, Va¨ keva¨ LH, Malignant melanoma in patients treated for psoriasis with methosalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med (1997) 336: 1041–5.
- Lindelo¨f B, Risk of melanoma with psoralen/ultraviolet. A therapy for psoriasis. Do the known risks now outweigh the benefits?. Drug Safety (1999) 20: 289–97.
- Frappaz A, Thivolet J, Calcipotriol in combination with PUVA: a randomized double blind placebo study in severe psoriasis. Eur J Dermatol (1993) 3: 351–4.
- Kokelj F, Plozzer C, Torsello P, Reduction of UV-A radiation induced by calcipotriol in the treatment of vulgar psoriasis with oral psoralen plus UV-A. Arch Dermatol (1997) 133: 668–9.
- Kragballe K, Beck HI, Soegaard H, Improvement of psoriasis by a topical vitamin D3 analogue (MC903) in a double-blind study. Br J Dermatol (1988) 119: 223–30.
- Kragballe K, Barnes L, Hamberg KJ, Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy. Br J Dermatol (1998) 139: 649–54.
- Molin L, Cutler TP, Helander I et al, Comparative efficacy of calcipotriol (MC 903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. Calcipotriol study group. Br J Dermatol (1997) 136: 89–93.
- Fredriksson T, Petterson U, Severe psoriasis - oral therapy with a new retinoid. Dermatologica (1978) 157: 238–44.
- Parrish JA, Fitzpatrick TB, Tanenbaum L et al, Photochemotherapy of psoriasis with oral methoxsalen and long wave ultraviolet light. N Engl J Med (1974) 291: 1207–11.
- Stern RS, Actinic degeneration and pigmentary change in association with psoralen and UVA treatment: a 20- year prospective study. J Am Acad Dermatol (2003) 48: 61–7.
- Bruynzeel I, Bergman W, Hartevelt HM et al, ‘High single-dose’ European PUVA regimen also causes an excess of non-melanoma skin cancer. J Dermatol (1991) 124: 49–55.
- Youn JI, Park BS, Park SB et al, Comparison of calcipotriol-PUVA with conventional PUVA in the treat- ment of psoriasis. J Dermatol Treat (2000) 11: 125–30.
- Schiffner R, Schiffner-Rohe J, Gerstenhauer M et al, Differences in efficacy between intention-to-treat and per-protocol analyses for patients with psoriasis vulgaris and atopic dermatitis: clinical and pharmacoeconomic implications. Br J Dermatol (2001) 144: 1154–60.